Does CARFILZOMIB Cause Ejection fraction abnormal? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Ejection fraction abnormal have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.1% of all adverse event reports for CARFILZOMIB.
10
Reports of Ejection fraction abnormal with CARFILZOMIB
0.1%
of all CARFILZOMIB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Ejection fraction abnormal From CARFILZOMIB?
Of the 10 reports, 2 (20.0%) resulted in death, 4 (40.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Ejection fraction abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Ejection fraction abnormal?
SACUBITRIL\VALSARTAN (452)
METOPROLOL (128)
APIXABAN (97)
SPIRONOLACTONE (97)
MONTELUKAST (93)
ALBUTEROL (90)
MOMETASONE FUROATE (85)
PREDNISONE (85)
BUPROPION (72)
LEVOTHYROXINE (72)
Which CARFILZOMIB Alternatives Have Lower Ejection fraction abnormal Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL